Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) — Net Asset Momentum

Latest YoY growth as of December 2025: +10.6%

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) recorded a net asset momentum of 10.6% as of December 2025, with net assets of CN¥93.99 Million CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Hangzhou TianMuShan Pharmaceutical Enter (600671) tangible equity ratio to evaluate the tangible quality of the company's equity base.

YoY Momentum

+10.6%
Year-over-year

Current Net Assets

CN¥93.99 Million
CNY · December 2025

Years of Data

33
1993 – 2025

Country

China
SHG

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Net Asset Momentum (1993–2025)

This chart tracks Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's year-over-year net asset growth across 33 annual reporting periods from 1993 to 2025. The most recent momentum reading is +10.6%, with net assets of CN¥93.99 Million CNY as of December 2025. Read total liabilities of Hangzhou TianMuShan Pharmaceutical Enter for a breakdown of total debt and financial obligations.

Annual Net Asset History for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1993–2025)

The table below shows the complete annual net asset history for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1993 to 2025, covering 33 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 600671 market cap overview.

Year Net Assets (CNY) Total Assets Total Liabilities YoY Momentum
2025 CN¥93.99 Million CN¥442.03 Million CN¥348.04 Million ▲ +10.6%
2024 CN¥85.02 Million CN¥441.46 Million CN¥356.44 Million ▲ +52.0%
2023 CN¥55.95 Million CN¥346.29 Million CN¥290.34 Million ▲ +1148.9%
2022 CN¥4.48 Million CN¥299.84 Million CN¥295.36 Million ▼ -93.1%
2021 CN¥64.56 Million CN¥402.65 Million CN¥338.09 Million ▼ -30.8%
2020 CN¥93.33 Million CN¥442.51 Million CN¥349.18 Million ▼ -30.0%
2019 CN¥133.33 Million CN¥526.93 Million CN¥393.60 Million ▲ +63.3%
2018 CN¥81.62 Million CN¥480.62 Million CN¥398.99 Million ▼ -15.2%
2017 CN¥96.27 Million CN¥450.44 Million CN¥354.18 Million ▲ +45.5%
2016 CN¥66.18 Million CN¥306.19 Million CN¥240.01 Million ▲ +5.5%
2015 CN¥62.76 Million CN¥280.38 Million CN¥217.63 Million ▼ -26.4%
2014 CN¥85.25 Million CN¥285.64 Million CN¥200.40 Million ▼ -10.5%
2013 CN¥95.26 Million CN¥325.27 Million CN¥230.01 Million ▲ +2.7%
2012 CN¥92.76 Million CN¥295.92 Million CN¥203.17 Million ▼ -49.3%
2011 CN¥182.84 Million CN¥357.84 Million CN¥175.00 Million ▲ +18.6%
2010 CN¥154.14 Million CN¥319.79 Million CN¥165.66 Million ▼ -17.9%
2009 CN¥187.74 Million CN¥328.27 Million CN¥140.53 Million ▼ -21.9%
2008 CN¥240.30 Million CN¥369.08 Million CN¥128.78 Million ▼ -15.1%
2007 CN¥282.93 Million CN¥414.09 Million CN¥131.16 Million ▲ +19.7%
2006 CN¥236.44 Million CN¥352.47 Million CN¥116.04 Million ▼ -1.2%
2005 CN¥239.39 Million CN¥372.71 Million CN¥133.32 Million ▼ -5.1%
2004 CN¥252.36 Million CN¥357.85 Million CN¥105.49 Million ▲ +4.0%
2003 CN¥242.64 Million CN¥346.52 Million CN¥103.88 Million ▼ -4.2%
2002 CN¥253.20 Million CN¥373.53 Million CN¥120.32 Million ▲ +0.6%
2001 CN¥251.63 Million CN¥408.75 Million CN¥157.11 Million ▲ +0.1%
2000 CN¥251.29 Million CN¥405.88 Million CN¥154.60 Million ▲ +2.9%
1999 CN¥244.10 Million CN¥339.78 Million CN¥95.68 Million ▲ +3.6%
1998 CN¥235.71 Million CN¥323.01 Million CN¥87.30 Million ▲ +4.6%
1997 CN¥225.25 Million CN¥295.69 Million CN¥70.44 Million ▲ +11.8%
1996 CN¥201.52 Million CN¥259.33 Million CN¥57.82 Million ▲ +15.8%
1995 CN¥174.02 Million CN¥263.02 Million CN¥89.00 Million
1994 CN¥0.00 CN¥192.12 Million CN¥192.12 Million ▼ -100.0%
1993 CN¥86.48 Million CN¥113.50 Million CN¥27.02 Million